Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06933875 · ClinicalTrials.gov registry record · NA
Promoting Palliative Care for People With Heart Failure
A NA study, sponsored by Yale University.
- Not yet
- Registry status
- NA
- Development phase
- 2,260
- Enrollment target
NCT06933875: Clinical Trial NA study, sponsored by Yale University.
NCT06933875 is a NA study that has not yet begun recruiting, run by Yale University. The registered enrollment target is 2,260 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06933875, a NA study, has not yet begun recruiting, sponsored by Yale University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 2,260 participants
- Enrollment target
Study Summary
This project will develop and test a novel clinical decision support tool (CDS) that encourages timely referral to palliative care for people hospitalized with heart failure. This intervention will incorporate an existing, validated 1-year mortality risk model into a CDS to deliver prognostic information and evidence-based decision support at the point of care. Thus, this research may lead to improved care-concordant and goal-directed care for people with heart failure.
Primary Outcome
System Usability Scale, 10-item Likert questionnaire. Total score range 0-100. Higher values indicate higher usability
Interventions
- BEHAVIORAL Clinical Decision Support Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,260 participants |
| Start Date | 2026-05-22 |
| Est. Completion | 2027-08-30 |
| Phase | NA |
What is known before NCT06933875 opens enrollment
NCT06933875 is an interventional study that assigns participants to a tested intervention. Its 2,260 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (61% higher).
The record links to 0 conditions, and to 1 intervention - of which Clinical Decision Support Tool is the first listed.
NCT06933875 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06933875 about?
NCT06933875 is a clinical study titled "Promoting Palliative Care for People With Heart Failure". This project will develop and test a novel clinical decision support tool (CDS) that encourages timely referral to palliative care for people hospitalized with heart failure. This intervention will incorporate an existing, validated 1-year mortality risk model into a CDS to deliver prognostic inform...
What is the current status of trial NCT06933875?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 2,260 participants. The study started on 2026-05-22. Estimated completion is 2027-08-30.
What interventions are being tested in trial NCT06933875?
The interventions under investigation include: Clinical Decision Support Tool (BEHAVIORAL).
Who is sponsoring clinical trial NCT06933875?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06933875's enrollment target sits among peer trials
2,260 48th of 2000 higher than 1,953 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03968393 · 2,270 participants · Phase 4
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
- NCT04889872 · 2,250 participants · NA
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVR
- NCT06805513 · 2,250 participants · Phase 3
Actual Use Trial of Tadalafil 5 mg
- NCT06939803 · 2,236 participants · NA
AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI